Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer
Molecular Pharmaceutics · 06.04.2026 · 23 (4) · 2720-2734
DOI: 10.1021/acs.molpharmaceut.5c01853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 03.03.2026. Verfasst von Harun Taş und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Translational Radiotheranostics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg 69120, Germany. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Kisspeptins, Receptors, Kisspeptin-1, Radiopharmaceuticals. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, Deutsches Krebsforschungszentrum, Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group Translational Radiotheranostics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg 69120, Germany.
- Service Unit for Radiopharmaceuticals and Preclinical Studies, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg 69120, Germany.
- Bayer AG, Berlin 13342, Germany.
- Bayer AG, Wuppertal 42113, Germany.
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc 77900, Czech Republic.
- Czech Advanced Technology and Research Institute, Palacký University, Olomouc 77900, Czech Republic.
ORCID-Profile: Harun Taş, Patrick Leopold Rüther, Elisabeth Pook, Miloš Petřík, Martina Benešová-Schäfer
Förderung
- Bayer
- Deutsches Krebsforschungszentrum
- Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy
Zitieren
APA
Taş, H., Schäfer, M., Shuja-Uddin, A., Bauder-Wüst, U., Kovacs Dos Santos, L., Bartnitzky, L., Oden, F., Platzk, M., König, T., Rüther, P. L., Pook, E., Dvořáková Bendová, K., Nový, Z., Petřík, M., Hagemann, U. B., & Benešová-Schäfer, M. (2026). Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer. Molecular Pharmaceutics, 23(4), 2720-2734. https://doi.org/10.1021/acs.molpharmaceut.5c01853
Vancouver
Taş H, Schäfer M, Shuja-Uddin A, Bauder-Wüst U, Kovacs Dos Santos L, Bartnitzky L, et al. Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer. Molecular Pharmaceutics. 2026;23(4):2720-2734. doi:10.1021/acs.molpharmaceut.5c01853
BibTeX
@article{Ta2026,
author = {Taş, Harun and Schäfer, Martin and Shuja-Uddin, Aneeba and Bauder-Wüst, Ulrike and Kovacs Dos Santos, Luciana and Bartnitzky, Lisa and Oden, Felix and Platzk, Magdalena and König, Tim and Rüther, Patrick Leopold and Pook, Elisabeth and Dvořáková Bendová, Kateřina and Nový, Zbyněk and Petřík, Miloš and Hagemann, Urs B and Benešová-Schäfer, Martina},
title = {Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {4},
pages = {2720--2734},
doi = {10.1021/acs.molpharmaceut.5c01853}
}
EUVIMED